Financials
Financial year 2025
SOCIETE NEUROLOGIE CLAES from Rouvroy, company number BE0656917256, closed financial year 2025 with a result of € 26,382 after tax. For that financial year SOCIETE NEUROLOGIE CLAES recorded a gross margin of € 62,949 and equity of € 86,572. Compared with financial year 2024, the result moved from € 19,068 to € 26,382. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
€ 86,572
▲ 42% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 26,382
▲ 38% vs 2024
Profit after tax over the fiscal year.
€ 109,326
▲ 96% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
3 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 1,409
▼ 33% vs 2024
No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.
€ 4,840
▲ 64% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 29,693
▼ 43% vs 2024
€ 23,988 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 2,004
▼ 4% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 12,203
▲ 13% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 86,156 | € 27,338 | € 48,501 | € 62,949 | ▲ 30% |
| Profit after taxes | € 30,570 | € -4,170 | € 19,068 | € 26,382 | ▲ 38% |
| Equity | € 73,838 | € 69,668 | € 61,023 | € 86,572 | ▲ 42% |
| Total debts | € 196,350 | € 104,743 | € 96,660 | € 52,389 | ▼ 46% |
| Cash | € 167,965 | € 78,677 | € 55,818 | € 109,326 | ▲ 96% |
| Land & buildings | € 2,876 | € 2,535 | € 2,193 | € 1,851 | ▼ 16% |
| Retained profit | € 55,238 | € 51,068 | € 42,423 | € 67,972 | ▲ 60% |
| Dividend | € 72,311 | € 0 | € 14,898 | € 833 | ▼ 94% |
| Bank debt | € 107,920 | € 88,880 | € 52,043 | € 29,693 | ▼ 43% |
| Balance sheet total | € 270,188 | € 174,411 | € 157,683 | € 138,961 | ▼ 12% |
Key figures of SOCIETE NEUROLOGIE CLAES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SOCIETE NEUROLOGIE CLAES?
What happened at SOCIETE NEUROLOGIE CLAES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 26,382 (▲ 38% vs 2024). Source: NBB ↗
- Frédérique Claes became a director. NBB
- New establishment in Arlon. KBO
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 30,570 profit in 2022 to € 26,382 profit in 2025.
Paid € 21,769 in corporate taxes since 2022.
Best year ever: 2022, with € 30,570 profit.
Paid out € 88,042 in dividends to the owners in total.
A new publication or filing at SOCIETE NEUROLOGIE CLAES? We notify you, reason included.
Follow SOCIETE NEUROLOGIE CLAESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SOCIETE NEUROLOGIE CLAES is Frédérique Claes.
Directors
According to the 2025 annual accounts
Frédérique Claes
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Rue Escofiette,Torgny 1
6767 Rouvroy
Rue de Bitburg 19 box 5
6700 Arlon
Active since 23 June 2016
Avenue de l'Hôpital 1
4000 Liège
Active since 23 June 2016
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0656.917.256
- VAT number
- BE 0656.917.256
- Registered office
- Rue Escofiette,Torgny 1, 6767 Rouvroy
- Names & denominations
- SOCIETE NEUROLOGIE CLAES · SONEUCLA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 June 2016
- Peppol
- Active · Active since 17 Sept 2025
- Contact
- [email protected]
- Activities · NACE
Activiteiten van medisch specialisten